BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11774034)

  • 1. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells.
    Erson AE; Niell BL; DeMers SK; Rouillard JM; Hanash SM; Petty EM
    Neoplasia; 2001; 3(6):521-6. PubMed ID: 11774034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.
    Wu GJ; Sinclair CS; Paape J; Ingle JN; Roche PC; James CD; Couch FJ
    Cancer Res; 2000 Oct; 60(19):5371-5. PubMed ID: 11034073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.
    Pärssinen J; Kuukasjärvi T; Karhu R; Kallioniemi A
    Br J Cancer; 2007 Apr; 96(8):1258-64. PubMed ID: 17353917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.
    Bärlund M; Monni O; Kononen J; Cornelison R; Torhorst J; Sauter G; Kallioniemi OLLI-P ; Kallioniemi A
    Cancer Res; 2000 Oct; 60(19):5340-4. PubMed ID: 11034067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 17q23 amplicon and breast cancer.
    Sinclair CS; Rowley M; Naderi A; Couch FJ
    Breast Cancer Res Treat; 2003 Apr; 78(3):313-22. PubMed ID: 12755490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
    Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
    Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
    Couch FJ; Wang XY; Wu GJ; Qian J; Jenkins RB; James CD
    Cancer Res; 1999 Apr; 59(7):1408-11. PubMed ID: 10197603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
    Bärlund M; Forozan F; Kononen J; Bubendorf L; Chen Y; Bittner ML; Torhorst J; Haas P; Bucher C; Sauter G; Kallioniemi OP; Kallioniemi A
    J Natl Cancer Inst; 2000 Aug; 92(15):1252-9. PubMed ID: 10922410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.
    Li J; Yang Y; Peng Y; Austin RJ; van Eyndhoven WG; Nguyen KC; Gabriele T; McCurrach ME; Marks JR; Hoey T; Lowe SW; Powers S
    Nat Genet; 2002 Jun; 31(2):133-4. PubMed ID: 12021784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
    Tan JM; Tock EP; Chow VT
    Mol Pathol; 2003 Apr; 56(2):109-15. PubMed ID: 12665628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer.
    Monni O; Barlund M; Mousses S; Kononen J; Sauter G; Heiskanen M; Paavola P; Avela K; Chen Y; Bittner ML; Kallioniemi A
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5711-6. PubMed ID: 11331760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
    Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
    Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution genomic and expression analyses of copy number alterations in breast tumors.
    Haverty PM; Fridlyand J; Li L; Getz G; Beroukhim R; Lohr S; Wu TD; Cavet G; Zhang Z; Chant J
    Genes Chromosomes Cancer; 2008 Jun; 47(6):530-42. PubMed ID: 18335499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
    Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
    BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.
    Mahmood SF; Gruel N; Chapeaublanc E; Lescure A; Jones T; Reyal F; Vincent-Salomon A; Raynal V; Pierron G; Perez F; Camonis J; Del Nery E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Carcinogenesis; 2014 Mar; 35(3):670-82. PubMed ID: 24148822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.
    Liu Y; Xu J; Choi HH; Han C; Fang Y; Li Y; Van der Jeught K; Xu H; Zhang L; Frieden M; Wang L; Eyvani H; Sun Y; Zhao G; Zhang Y; Liu S; Wan J; Huang C; Ji G; Lu X; He X; Zhang X
    Nat Commun; 2018 Nov; 9(1):4718. PubMed ID: 30413718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERBB2 amplifications in esophageal adenocarcinoma.
    Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
    Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
    Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
    Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.